Covid-19. Covid-19 disease
Conditions
Interventions
Intervention 1: Intervention group: 30 people receiving plasma cluster and routine treatment. Intervention 2: Control group: Routine treatment equal to 30 people.
Sponsors
Bojnourd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Mild to moderate-grade Covid-19 patients Since the start of their symptoms, a maximum of 7 days have elapsed. Between the ages of 18 and 50, Fill out the informed consent form and sign it.
Exclusion criteria
Exclusion criteria: Women who are pregnant or breastfeeding Using immunosuppressive medications Using sedatives and serotonin reuptake inhibitors Addiction to drugs underlying illness (chronic kidney and liver disease; brain and heart disease, pulmonary and hypertension; cancer, endocrine and metabolic diseases; thyroid disorders; immune deficiencies, Alzheimer's, multifocal failure, encephalopathy, and neuropathy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improve symptoms based on checklist. Timepoint: Patients are monitored before the study and monitored 24 hours after the intervention. Then patients at weekly intervals for 4 weeks after the intervention in terms of clinical improvement by measuring body temperature, cough (zero or mild). And myalgia that is stable for at least 24 hours or the patient is hospitalized. Method of measurement: Researcher checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmohammad amin younesi
Bojnourd University of Medical Sciences
Outcome results
None listed